These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26050985)

  • 1. Tiotropium and its efficacy in the treatment of COPD.
    Kupczyk M; Szepiel P; Kuna P
    Pneumonol Alergol Pol; 2015; 83(3):229-37. PubMed ID: 26050985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined bronchodilators (tiotropium plus olodaterol) for patients with chronic obstructive pulmonary disease.
    Ramadan WH; Kabbara WK; El Khoury GM; Al Assir SA
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2347-56. PubMed ID: 26586940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profile of a fixed-dose combination of tiotropium/olodaterol and its potential in the treatment of COPD.
    Muruganandan S; Jayaram L
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1179-89. PubMed ID: 26124657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early impact of treatment with tiotropium, long-acting anticholinergic preparation, in patients with COPD - real-life experience from an observational study.
    Jahnz-Różyk K; Szepiel P
    Int J Chron Obstruct Pulmon Dis; 2015; 10():613-23. PubMed ID: 25834420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of COPD Treatments: A Multicriteria Decision Analysis of Aclidinium and Tiotropium in the United States.
    Marsh K; Zaiser E; Orfanos P; Salverda S; Wilcox T; Sun S; Dixit S
    Value Health; 2017 Jan; 20(1):132-140. PubMed ID: 28212954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of tiotropium on night-time awakening and daily rescue medication use in patients with COPD.
    Calverley PM; Rennard SI; Clerisme-Beaty E; Metzdorf N; Zubek VB; ZuWallack R
    Respir Res; 2016 Mar; 17():27. PubMed ID: 26971242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olodaterol + tiotropium bromide for the treatment of chronic obstructive pulmonary disease.
    Cazzola M; Rogliani P; Ora J; Matera MG
    Expert Rev Clin Pharmacol; 2015; 8(5):529-39. PubMed ID: 26294073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-Effectiveness of Glycopyrronium Bromide Compared with Tiotropium in Patients with Chronic Obstructive Pulmonary Disease in Sweden.
    Costa-Scharplatz M; Ställberg B; Goyal P; Asukai Y; Gruenberger JB; Price D
    Appl Health Econ Health Policy; 2015 Dec; 13(6):637-45. PubMed ID: 26324401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 24-h lung-function profile of once-daily tiotropium and olodaterol fixed-dose combination in chronic obstructive pulmonary disease.
    Beeh KM; Westerman J; Kirsten AM; Hébert J; Grönke L; Hamilton A; Tetzlaff K; Derom E
    Pulm Pharmacol Ther; 2015 Jun; 32():53-9. PubMed ID: 25956072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of tiotropium on heart rate variability in stable chronic obstructive pulmonary disease patients.
    Wu YK; Huang CY; Yang MC; Huang GL; Chen SY; Lan CC
    J Aerosol Med Pulm Drug Deliv; 2015 Apr; 28(2):100-5. PubMed ID: 24840562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tiotropium/olodaterol (Stiolto Respimat) for COPD.
    Med Lett Drugs Ther; 2015 Nov; 57(1482):161-2. PubMed ID: 26583607
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-acting muscarinic antagonists for the prevention of exacerbations of chronic obstructive pulmonary disease.
    Jones PW
    Ther Adv Respir Dis; 2015 Jun; 9(3):84-96. PubMed ID: 25801643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of tiotropium bromide (Spiriva) in patients with chronic-obstructive pulmonary disease (COPD) of different severities].
    Beeh KM; Beier J; Buhl R; Stark-Lorenzen P; Gerken F; Metzdorf N;
    Pneumologie; 2006 Jun; 60(6):341-6. PubMed ID: 16761228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tiotropium (Spiriva) - a long-acting inhaled anticholinergic for the treatment of chronic obstructive pulmonary disease (COPD)].
    Beeh KM; Welte T; Buhl R
    Pneumologie; 2003 Sep; 57(9):519-25. PubMed ID: 13680472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bronchodilator therapy in the prevention of COPD exacerbations].
    Sobradillo Ecenarro P; García-Rivero JL; López Caro JC
    Semergen; 2019 Oct; 45(7):479-488. PubMed ID: 31540819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Tiotropium Safety and Performance in Respimat® (TIOSPIR®) Trial: Spirometry Outcomes.
    Anzueto A; Wise R; Calverley P; Dusser D; Tang W; Metzdorf N; Dahl R
    Respir Res; 2015 Sep; 16(1):107. PubMed ID: 26369563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UPLIFT study - understanding potential long-term impacts on function with tiotropium - and sub-analyses. Bibliographic resume of the obtained results.
    Callejas González FJ; Genovés Crespo M; Cruz Ruiz J; Godoy Mayoral R; Agustín Martínez FJ; Martínez García AJ; Tárraga López PJ
    Expert Rev Respir Med; 2016 Sep; 10(9):1023-33. PubMed ID: 27176208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tiotropium bromide: a new long-acting bronchodilator for the treatment of chronic obstructive pulmonary disease.
    Koumis T; Samuel S
    Clin Ther; 2005 Apr; 27(4):377-92. PubMed ID: 15922812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tiotropium: a new therapeutic option in chronic obstructive pulmonary disease].
    Corhay JL; Louis R
    Rev Med Suisse; 2005 Aug; 1(30):1967-9, 1971-2. PubMed ID: 16200941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tiotropium as new quality medication in the COPD management].
    Lubiński W; Płusa T
    Pol Merkur Lekarski; 2006 Jan; 20(115):5-7. PubMed ID: 16617725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.